Current Diagnosis and Management in Urothelial Carcinomas

Dear Colleagues,

We are delighted to present this Special Issue focusing on diagnostics and management in urothelial carcinomas, a subset of urologic malignancies with unique challenges and clinical implications. Urothelial carcinomas, which primarily affect the bladder but can also arise in the upper urinary tract, represent a significant burden on healthcare systems worldwide. Despite advancements in diagnostic techniques and therapeutic options, urothelial carcinomas continue to pose challenges in early detection, accurate staging and effective management.

This Special Issue aims to provide a comprehensive overview of the latest developments and innovations in the diagnosis and management of urothelial carcinomas. From emerging biomarkers and genomic profiling to advancements in imaging modalities such as multiparametric MRI and PET-CT, we seek to explore the evolving landscape of diagnostic strategies in urothelial cancer care.

We invite researchers, clinicians and experts in the field to contribute original research articles, review papers and case studies that delve into various aspects of the current diagnostics and management strategies specific to urothelial carcinomas. By consolidating insights from multidisciplinary perspectives, we aim to facilitate a deeper understanding of diagnostic challenges and opportunities in urothelial cancer management, ultimately striving toward enhanced patient outcomes and quality of care.

We look forward to receiving your contributions and shaping this Special Issue, which we envision as a pivotal resource for advancing the field of urothelial carcinoma diagnostics and management.

Dr. Simone Morra
Dr. Francesco Di Bello
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Diagnostics is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• urothelial cancer
• emerging biomarkers
• genomic profiling
• imaging modalities
• current diagnostics and management strategies